DHEAS Deficiency During Consumption of Sustained-Action Prescribed Opioids: Evidence for Opioid-Induced Inhibition of Adrenal Androgen Production

Journal of Pain

Volumn 7, Issue 12, 2006, Pages 901-907

  Daniell, Harry W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

adrenal cortex hormones; adrenal insufficiency; corticotropin; DHEAS; hypogonadism; Opioid

Indexed keywords

CODEINE; CORTICOTROPIN; FENTANYL; HYDROCODONE; METHADONE; MORPHINE SULFATE; OPIATE; OXYCODONE; PRASTERONE SULFATE;

ADRENAL INSUFFICIENCY; ADULT; AGE DISTRIBUTION; AGED; ANDROGEN DEFICIENCY; ANDROGEN SYNTHESIS; ARTICLE; BACKACHE; BODY MASS; CIGARETTE SMOKING; CLINICAL ARTICLE; CONTROLLED STUDY; CRITERION RELATED VALIDITY; DEPRESSION; DOSE RESPONSE; DRUG MEGADOSE; ERECTILE DYSFUNCTION; FATIGUE; FEMALE; GONADOTROPIN BLOOD LEVEL; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; LIBIDO DISORDER; MALE; NIGHT SWEAT; OSTEOPOROSIS; OUTPATIENT; PAIN; SIDE EFFECT; SINGLE DRUG DOSE;

ADRENAL GLANDS; ADRENOCORTICOTROPIC HORMONE; ADULT; AGE FACTORS; AGED; ANALGESICS, OPIOID; ANDROGENS; DEHYDROEPIANDROSTERONE SULFATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; SEX FACTORS;

EID: 33845189661     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2006.04.011     Document Type: Article

References (45)

1. Abs R., Verhelst J., Maeyaert J., Van Buyten J.P., Opsomer F., Adriaensen H., Verloyy J., Van Havenbergh T., Smet M., and Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 85 (2000) 2215-2222
2. Allolio B., Schulte H.M., Deusb U., Kallabis D., Hamel E., and Winkelman W. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. Acta Endocrinol (Copenh) 114 (1987) 509-514
3. Arlt W., Callies F., van Vlijmen J., Koehler I., Reincke M., Bidlingmaier M., Huebler D., Oettel M., Ernst M., Schulte H., and Allolio B. Dehydroepiandrosterone replacement in women with adrenal insufficiency. N Engl J Med 341 (1999) 1013-1020
4. Couzinet B., Meduri G., Lecce M., Young J., Brailly S., Loosfelt H., Milgrom E., and Schaison G. The postmenopausal ovary is not a major androgen-producing gland. J Clin Endocrinol Metab 86 (2001) 5060-5066
5. Cutler Jr. G.B., Davis E., Johnsonbaugh R.E., and Loriaux D.L. Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. J Clin Endocrinol Metab 49 (1979) 604-609
6. Cutolo M., Straub R.H., Foppiani L., Prete C., Pulsatelli L., Sulli A., Boiardi L., Macchioni P., Giusti M., Pizzorni C., Seriolo B., and Salvarani C. Adrenal gland hypofunction in active polymyalgia rheumatica. Effect of glucocorticoids treatment on adrenal hormones and interleukin 6. J Rheumatol 29 (2002) 748-756
7. Cutolo M., Sulli A., Pizzorni C., Craviotto C., and Straub R.H. Hypothalamic-pituitary-adrenocortical and gonadal functions in rheumatoid arthritis. Ann N Y Acad Sci 992 (2003) 107-117
8. Dackis C.A., Gurpegui M., Pottash A.L.C., and Gold M.S. Methadone induced hypoadrenalism. Lancet 2 (1982) 1167
9. Daniell H.W. Hypogonadism in men consuming sustained-action oral opioids. J Pain 3 (2002) 377-384
10. Daniell H.W., Lentz R., and Mazer N.A. Open-label pilot study of testosterone patch therapy in men. J Pain 7 (2006) 200-210
11. Dhatariya K., and Nair K. Dehydroepiandrosterone: Is there a role for replacement?. Mayo Clin Proc 78 (2003) 1257-1273
12. Facchinetti F., Comitini G., Petraglia F., Volpe A., and Genazzani A.R. Reduced estriol and dehydroepiandrosterone sulphate plasma levels in methadone-addicted pregnant women. Eur J Obstet Gynecol Reprod Biol 23 (1986) 67-73
13. Facchinetti F., Volpe A., Farci G., Petraglia F., Porro C.A., Barbieri G., Cioni A., Balestrieri A., and Genazzani A.R. Hypothalamus-pituitary-adrenal axis of heroin addicts. Drug Alcohol Depend 15 (1985) 361-366
14. Faletti A., Mastronardi C., Lomniczi A., Seilicovich A., Gimeno M., McCann S., and Rettori V. β-Endorphin blocks luteinizing hormone-releasing hormone release by inhibiting the nitricoxidergic pathway controlling its release. Proc Natl Acad Sci U S A 96 (1999) 1722-1726
15. Field A.E., Colditz G.A., Willett W.C., Longcope C., and McKinlay J.B. The relation of smoking, age, relative weight, and dietary intake to serum adrenal steroids, sex hormones, and sex hormone-binding globulin in middle-aged men. J Clin Endocrinol Metab 79 (1994) 1310-1316
16. Gold P.W., Extein I., Pickar D., Rebar R., Ross R., and Goodwin F.K. Suppression of plasma cortisol in depressed patients by acute intravenous methadone infusion. Am J Psychiatry 137 (1980) 862-863
17. Hall G.M., Lacoumenta S., Hart G.R., and Burrin J.M. Site of action of fentanyl in inhibiting the pituitary-adrenal response to surgery in man. Br J Anaesth 65 (1990) 251-253
18. Hunt P.J., Gurnell E.M., Huppert F.A., Richards C., Prevost A.T., Wass J.A., Herbert J., and Chatterjee V.K. Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial. J Clin Endocrinol Metab 85 (2000) 4650-4656
19. Ibanez L., Potau N., Marco M.V., and de Zegher F. Corticotropin-releasing hormone: a potent androgen secretagogue in girls with hyperandrogenism after precocious pubarche. J Clin Endocrinol Metab 84 (1999) 4602-4606
20. Isojarvi J.I., Pakarinen A.J., Ylipalosaari P.J., and Myllyla V.V. Serum hormones in male epileptic patients receiving anticonvulsant medication. Arch Neurol 47 (1990) 670-676
21. Johannsson G., Burman P., Wiren L., Engstrom B.E., Nilsson A.G., Ottosson M., Jonsson B., Bengtsson B.A., and Karlsson F.A. Low dose dehydroepiandrosterone affects behavior in hypopituitary androgen-deficient women: a placebo-controlled trial. J Clin Endocrinol Metab 87 (2002) 2046-2052
22. Kannisto S., Korppi M., Remes K., and Voutilainen R. Serum dehydroepiandrosterone sulfate concentration as an indicator of adrenocortical suppression in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 86 (2001) 4908-4912
23. Khaw K.T., Chir M.B.B., Tazuke S., and Barrett-Connor E. Cigarette smoking and levels of adrenal androgens in postmenopausal women. N Engl J Med 318 (1988) 1705-1709
24. Kraemer R., Synovitz L., Gimpel T., Kraemer G., Johnson L., and Castracane V. Effect of estrogen on serum DHEA in younger and older women and the relationship of DHEA to adiposity and gender. Metabolism 50 (2001) 488-493
25. Kroboth P., Salek F., Pittenger A., Fabian T., and Frye R. DHEA and DHEA-S: A review. J Clin Parmcol 39 (1999) 327-348
26. McKenna T.J., Fearon U., Clarke D., and Cunningham S.K. A critical review of the origin and control of adrenal androgens. Baillieres Clin Obstet Gynaecol 11 (1997) 229-248
27. Mendelson J.H., Sholar M.B., Goletiani N., Siegel A.J., and Mello N.K. Effects of low-and high-nicotine cigarette smoking on mood states and the HPA axis in men. Neuropsychopharmacology 17 (2004) 16-29
28. Nasrallah M.P., and Arafah B.M. The value of dehydroepiandrosterone sulfate measurements in the assessment of adrenal function. J Clin Endocrinol Metab 88 (2003) 5293-5298
29. Oltmanns K., Fehm H., and Peters A. Chronic fentanyl application induces adrenocortical insufficiency. J Intern Med 257 (2005) 478-480
30. Palm S., Moenig H., and Maier C. Effects of oral treatment with sustained release morphine tablets on hypothalamic-pituitary-adrenal axis. Methods Find Exp Clin Pharmacol 19 (1997) 269-273
31. Parker L.N. Control of adrenal androgen secretion. Endocrinol Metab Clin North Am 20 (1991) 401-421
32. Parker L.N., and Odell W.D. Evidence for existence of cortical androgen-stimulating hormone. Am J Physiol 236 (1979) E616-E620
33. Polderman K., Gooren L., and van der Veen E. Effects of gonadal androgens and oestrogens on adrenal androgen levels. Clin Endocrinol 43 (1995) 415-421
34. Raff H., Norton A., Flemma R., and Findling J. Inhibition of the adrenocorticotropin response to surgery in humans: Interaction between dexamethasone and fentanyl. J Clin Endocrinol Metab 65 (1987) 295
35. Rajagopal A., Vassilopoulou-Sellin R., Palmer J., Kaur G., and Bruera E. Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids. Cancer 100 (2004) 851-858
36. Rittmaster R.S., Loriaux D.L., and Cutler Jr. G.B. Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women. J Clin Endocrinol Metab 61 (1985) 462-466
37. Rittmaster R.S., Cutler Jr. G.B., Sobel D.O., Goldstein D.S., Koppelman M.C., Loriaux D.L., and Chrousos G.P. Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. J Clin Endocrinol Metab 60 (1985) 891-895
38. Sasaki A., Sato S., Murakami O., Go M., Inoue M., Shimizu Y., Hanew K., Andoh N., Sato I., Sasano N., and Yoshinaga K. Immunoreactive corticotrophin-releasing hormone present in human plasma may be derived from both hypothalamic and extrhypothalamic sources. J Clin Endocrinol Metab 65 (1987) 176-182
39. Simon J., Klaiber E., Wiita B., Bowen A., and Yang H.M. Differential effects of estrogen-androgen and estrogen-only therapy on vasomotor symptoms, gondotropin secretion, and endogenous androgen bioavailability in postmenopausal women. Menopause 6 (1999) 138-146
40. Smith R., Mesiano S., Chan E.C., Brown S., and Jaffe R.B. Corticotropin-releasing hormone directly and preferentially stimulates dehydroepiandrosterone sulfate secretion by human fetal adrenal cortical cells. J Clin Endocrinol Metab 83 (1998) 2916-2920
41. Strous R.D., Maayan R., Lapidus R., Stryjer R., Lustig M., Kotler M., and Weizman A. Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch Gen Psychiatry 60 (2003) 133-141
42. Szostak-Wegierek D., Bjorntorp P., Marin P., Lindstedt G., and Andersson B. Influence of smoking on hormone secretion in obese and lean female smokers. Obesity Res 4 (1996) 321-328
43. van Vollenhoven R.F., Engleman E.G., and McGuire J.L. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 38 (1995) 1826-1831
44. Wolkowitz O.M., Reus V.I., Keebler A., Nelson N., Friedland M., Brizendine L., and Roberts E. Double-blind treatment of major depression with dehydroepiandrosterone. Am J Psychiatry 156 (1999) 646-649
45. Zis A., Haskett R., Albala A., and Carroll B. Morphine inhibits cortisol and stimulates prolactin secretion in man. Psychoneuroendocrinology 9 (1984) 423-427